This content is machine translated Giant cell arteritis Indication expansion of Actemra® in Switzerland Until now, only high-dose steroids have been available for the potentially life-threatening autoimmune disease giant gall arteritis. This has changed with the first commercially available non-steroidal biotherapeutic targeting the IL-6…
